National Allergy Research Centre, Department of Skin and Allergy, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.
LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
J Allergy Clin Immunol. 2022 Apr;149(4):1162-1171. doi: 10.1016/j.jaci.2022.02.002. Epub 2022 Feb 18.
Contact dermatitis is a common disease that is caused by repeated skin contact with contact allergens or irritants, resulting in allergic contact dermatitis (ACD) and/or irritant contact dermatitis. Attempts have been made to identify biomarkers to distinguish irritant and allergic patch test reactions, which could aid diagnosis. Some promising candidates have recently been identified, but verification and validation in clinical cases still need to be done. New causes of ACD are constantly being recognized. In this review, 10 new contact allergens from recent years, several relating to anti-aging products, have been identified. Frequent allergens causing considerable morbidity in the population, such as the preservative methylisothiazolinone, have been regulated in the European Union. A significant drop in the number of cases has been seen, whereas high rates are still occurring in other areas such as North America. Other frequent causes are fragrance allergens, especially the widely used terpenes and acrylates found in medical devices for control of diabetes. These represent unsolved problems. Recent advances in immunology have opened the way for a better understanding of the complexity of contact dermatitis, especially ACD-a disease that may be more heterogenous that previous understood, with several subtypes. With the rapidly evolving molecular understanding of ACD, the potential for development of new drugs for personalized treatment of contact dermatitis is considerable.
接触性皮炎是一种常见疾病,由反复接触接触过敏原或刺激物引起皮肤接触导致的,包括过敏性接触性皮炎(ACD)和/或刺激性接触性皮炎。目前,人们已经尝试寻找生物标志物来区分刺激性和过敏性斑贴试验反应,这有助于诊断。最近已经确定了一些有前途的候选标志物,但仍需要在临床病例中进行验证和确认。新的 ACD 病因不断被认识。在这篇综述中,我们确定了近年来 10 种新的接触过敏原,其中一些与抗衰老产品有关。在欧盟,经常引起人群发病率较高的过敏原,如防腐剂甲基异噻唑啉酮,已经受到监管。在欧洲,接触性皮炎的病例数量显著下降,而在北美等其他地区仍有较高的发病率。其他常见的原因是香料过敏原,尤其是在用于控制糖尿病的医疗器械中广泛使用的萜烯和丙烯酸酯。这些都是尚未解决的问题。免疫学的最新进展为更好地理解接触性皮炎的复杂性,特别是 ACD 开辟了道路,ACD 可能比以前认为的更为异质,有几种亚型。随着对 ACD 的分子理解的迅速发展,为接触性皮炎的个性化治疗开发新药物的潜力巨大。